Efficient medicine may treat neuropathic pain
A successful clinical test has been completed by Meditop Gyógyszeripari Kft. which can bring the long-awaited breakthrough in the development of a special-purpose painkiller. The project was awarded almost HUF 500 million (EUR 1.59 million) from the Research and Technology Innovation Fund under a programme supporting market-oriented R&D activities, which was used by the Hungarian pharmaceutical company to prepare and conduct the Phase II clinical test of a new combination medicine for the treatment of neuropathic pain.
Publication date: 26 July 2016